New AI system revolutionizes drug design and vaccine development
The rapid advancement of artificial intelligence (AI) is transforming the field of structural biology. In May 2024, DeepMind…
Computational exploration of global venoms for antimicrobial discovery with Venomics artificial intelligence
Mining venoms for antimicrobials We sourced venom proteins from four databases: ConoServer (focusing on conopeptides, Supplementary Fig. 1)31,…
Hong Kong start-up IntelliGen AI aims to challenge Google DeepMind in drug discovery
IntelliGen AI, an artificial intelligence (AI) start-up founded in Hong Kong, is positioning itself as a competitor to…
Japan’s Oldest Pharma Firm to Be Sold to Bain Capital
Mitsubishi Tanabe Pharma, Japan’s oldest pharmaceutical company with a 350-year history, is approaching a major turning point. Its…
Why Drug Discovery Needs Robots and Artificial Intelligence
IntroductionAn Introduction to AI in Drug DiscoveryThe Drug Discovery ProblemRobotics in the LabThe Role of AIChallengesThe FutureConclusionReferences Discover…
CN Bio expands access to OOC solutions for APAC customers with distributor agreement in South Korea
CN Bio, a leading provider of Organ-on-a-chip (OOC) systems and solutions that accelerate drug discovery and development workflows,…
Insilico, U. Toronto Researchers Develop Quantum-Classical Computing AI Model
Quantum computing and artificial intelligence (AI) can be combined with classical computing methods to design and discover small-molecule…
Ten Companies to Watch in AI Drug Discovery
Big investments in artificial intelligence (AI) don’t guarantee big wins. This point was emphasized by Niven R. Narain,…